DERBYSHIRE COMMUNITY HEALTH SERVICES NHS FOUNDATION TRUST 2023

Dear Mrs Wendy Micklewright



As requested .

Freedom of Information 2024/168



Q1

 

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: -

1.Please supply patient’s information ECT leaflet

2.Please supply patient ECT consent form

3.Please supply any ECT reports/investigations

4.How many ECT in 2023?

5.What proportion of patients were men/women?

6.How old were they?

7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

8.How many people covered by the equality act received ECT ?

9.How many people were offered talking therapy prior to ECT ?

10.How many were receiving ECT for the first time?

11.How many patients consented to ECT?

12.How many ECT complaints were investigated outside the NHS and CCG?

13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?

14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?

15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?

16.How many patients have suffered complications during and after ECT and what were those complications?

17.Have there been any formal complaints from patients/relatives about ECT?

18.If so, what was their concerns?

19.How many patients report memory loss/loss of cognitive function?

20.What tests are used to assess memory loss/loss of cognitive function?

21.Have MRI or CT scans been used before and after ECT?

22.If so, what was the conclusion?

23.How does the Trust plan to prevent ECT in the future?

 

A1

 

We do not provide ECT in DCHS.

Q2

Please provide restraints information under the FOI act to the following questions: -

1.Please supply any Restraints/investigations

2.How many RESTRAINTS in 2023?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many people covered by the equality act were restrained?

7.How many RESTRAINTS were investigated outside the NHS and CCG?

8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?

11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?

12.Have there been any formal complaints from patients/relatives about RESTRAINTS?

13.If so, what was their concerns?

14.Are counts of forced injections available?

15.How does the Trust plan to reduce restraints in the future?

A2

Q1 external reviews undertaken in line with NICE NG10 guidance – however these

are patient identifiable and cannot be shared.

Q2 112 – 76 OPMH service / 36 ND service

Q3 72.7% male / 27.3% female

Q4 age ranges from 25 years onwards

Q5none

Q6 100% of patients

Q7 none

Q8 none

Q9 not known as patients discharged from our service.

Q10 not known.

Q11 none reported.

Q12 none reported.

Q13 n/a

Q14 yes

Q15 use of force policy developed outlining principles of restraint reduction including. easy read, reducing restrictive practice strategy in development, model of training amended to be in line with RRN model. Debrief models developed including patient debrief

Q3

Please provide SECLUSION information under the FOI act to the following questions: -

1.Please supply any SECLUSION reports/investigations

2.How many SECLUSIONS in 2023?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many people covered by the Equality Act were secluded ?

7.How many SECLUSIONS were investigated outside the NHS and CCG?

8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?

11.How many patients have suffered complications during and after SECLUSION and what were those complications?

12.Have there been any formal complaints from patients/relatives about SECLUSION?

13.If so, what was their concerns?

14.How does the Trust plan to reduce SECLUSIONS in the future?

 

A3

Q1external reviews undertaken in line with NICE NG10 guidance – however these

are patient identifiable and cannot be shared.

Q2 3

Q3 100% male

Q4 71 years / 37 years

Q5 none

Q6 3

Q7 0

Q8 0

Q9 0

Q10 0

Q11 0

Q12 0

Q13 0

Q14 use of force policy developed outlining principles of restraint reduction including easy read, reducing restrictive practice strategy in development, model of training amended to be in line with RRN model. Debrief models developed including patient debrief

 

Q4

Please provide MEDICATION ERRORS information under the FOI act to the following questions: -

1.Please supply any MEDICATION ERRORS reports/investigations

2.How many MEDICATION ERRORS in 2023?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many people covered by the equality act endured medication errors ?

7.How many MEDICATION ERRORS were investigated outside the NHS and CCG?

8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?

11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?

12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?

13.If so, what was their concerns?

14.How does the Trust plan to prevent MEDICATION ERRORS in the future

A4

  1. There have been no medication incidents meeting the criteria for Patient Safety Incident Investigation (PSII) within this period therefore no formal investigation reports available

  2. 756 Patient Safety Incidents relating to medication were reported in 2023, including some which are third party incidents, however not all reported incidents will be errors. This figure includes incidents relating to transport or storage of medication and includes ‘near miss’ incidents where an error may have occurred but was prevented due to identification and action.

  3.  

Male

45%

Female

52%

Not stated/Unknown

3%

4.

Age range

Number of incidents

0 - 15

3

16 – 24

2

25 - 34

9

35 - 44

19

45 - 54

25

55 - 64

96

65 - 74

149

75 - 84

217

85 plus

236

Grand total

756

5.Not reported

 

6. Not reported

 

7. 0

 

8. Not reported – see question 11

 

9. Not reported – see question 11

 

10. Not reported – see question 11

 

11.Harm classified and reported using NHS England reporting criteria

 

 

Number of incidents

No injury or harm

712

Minor (low harm or injury)

44

Significant (moderate harm or injury)

0

Major harm or injury

0

Fatal

0

Grand total

756

 

12. None

 

13. None

 

14.Information available via NHS Patient Safety Strategy, NHS England Patient Safety Incident Response Framework (PSIRF), DCHS Incident Reporting Policy, DCHS Patient Safety Incident Response Plan (PSIRP)